$0.07
(0.40%)
Add to watchlist
Create an alert
Stocks and Shares ISATakeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
Company Information
About this company
Key people
Christophe Weber
President, Chief Executive Officer, Representative Director
Milano Furuta
Chief Financial Officer, Director
Andrew S. Plump
President of Research & Development, Director
Masami Iijima
Chairman of Board of Directors, Independent Director
Jean-Luc Butel
Independent Director
Ian T. Clark
Independent Director
Yoshiaki Fujimori
Independent Director
Steven H. Gillis
Independent Director
Click to see more
Key facts
- Shares in issue1.59bn
- EPICTAK
- ISINUS8740602052
- LocationJapan
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$54.48bn
- Employees47,455
- ExchangeNew York Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.